Swedbank Robur Healthcare A
All about the fund Swedbank Robur Healthcare A, which stocks or funds the fund owns, and how much the fund owns of each holding.
Details
Similar Funds
Find funds with similar holdings as Swedbank Robur Healthcare here:
Security |
Fee |
1 |
Fidelity Sustainable Healthcare Fund A Euro The fund's holdings match to 60% The fund's fee of 1,50% is 0,2 higher |
(i) |
1,50 % |
2
 |
Avanza Healthcare by Samuelsson & Hult The fund's holdings match to 48% The fund's fee of 1,25% is 0,05 lower |
(i) |
1,25 % |
3 |
BGF World Healthscience A2 The fund's holdings match to 36% The fund's fee of 2,17% is 0,87 higher |
(i) |
2,17 % |
Holdings
The fund Swedbank Robur Healthcare A has 28 holdings, with the largest being UnitedHealth at 8.49%, followed by Eli Lilly at 8.12% and AstraZeneca at 6.21%.
All Holdings
Here are all holdings in Swedbank Robur Healthcare:
# |
Security |
|
Share |
1 |
 |
UnitedHealth Group Inc US91324P1021 |
(i) |
8.49 % |
2 |
 |
Eli Lilly and Co US5324571083 |
(i) |
8.12 % |
3 |
 |
AstraZeneca GB0009895292 |
(i) |
6.21 % |
4 |
 |
Novo Nordisk B DK0060534915 |
(i) |
5.78 % |
5 |
 |
AbbVie Inc US00287Y1091 |
(i) |
5.01 % |
6 |
 |
Merck & Co Inc US58933Y1055 |
(i) |
4.71 % |
7 |
|
Thermo Fisher Scientific Inc US8835561023 |
(i) |
4.45 % |
8 |
 |
McKesson Corp US58155Q1031 |
(i) |
4.27 % |
9 |
 |
Abbott Laboratories US0028241000 |
(i) |
4.24 % |
10 |
 |
Danaher Corp US2358511028 |
(i) |
4.03 % |
11 |
 |
Roche Holding AG CH0012032048 |
(i) |
3.84 % |
12 |
|
Boston Scientific Corp US1011371077 |
(i) |
3.73 % |
13 |
|
Centene Corp US15135B1017 |
(i) |
3.56 % |
14 |
|
Vertex Pharmaceuticals Inc US92532F1003 |
(i) |
3.28 % |
15 |
 |
Sanofi SA US80105N1054 |
(i) |
2.96 % |
16 |
|
HCA Healthcare Inc US40412C1018 |
(i) |
2.76 % |
17 |
 |
Merck KGaA DE0006599905 |
(i) |
2.19 % |
18 |
|
Cooper Companies Inc US2166484020 |
(i) |
1.78 % |
19 |
|
Edwards Lifesciences Corp US28176E1082 |
(i) |
1.62 % |
20 |
 |
Takeda Pharmaceutical Co Ltd JP3463000004 |
(i) |
1.55 % |
21 |
|
Hologic Inc US4364401012 |
(i) |
1.43 % |
22 |
|
IQVIA Inc US46266C1053 |
(i) |
1.36 % |
23 |
|
Royalty Pharma Plc GB00BMVP7Y09 |
(i) |
1.36 % |
24 |
|
Halozyme Therapeutics Inc US40637H1095 |
(i) |
0.91 % |
25 |
|
ConvaTec Group Plc GB00BD3VFW73 |
(i) |
0.83 % |
Denmark
5.8% of the fund's holdings are from Denmark.
 | Novo Nordisk B 5.78% |
France
3% of the fund's holdings are from France.
 | Sanofi SA 2.96% |
Germany
6.9% of the fund's holdings are from Germany.
 | Merck KGaA 2.19% |
 | Merck & Co Inc 4.71% |
Japan
1.6% of the fund's holdings are from Japan.
 | Takeda Pharmaceutical Co Ltd 1.55% |
Sweden
6.2% of the fund's holdings are from Sweden.
 | AstraZeneca 6.21% |
Switzerland
3.8% of the fund's holdings are from Switzerland.
 | Roche Holding AG 3.84% |
UK
6.2% of the fund's holdings are from UK.
 | AstraZeneca 6.21% |
The list of fund holdings was last updated on April 13, 2025.